Intelligent Bio Solutions Files 8-K on Shareholder Nominations

Ticker: INBS · Form: 8-K · Filed: Mar 14, 2025 · CIK: 1725430

Sentiment: neutral

Topics: governance, shareholder-nomination, sec-filing

TL;DR

Intelligent Bio Solutions filed an 8-K about shareholder nominations - board changes might be brewing.

AI Summary

Intelligent Bio Solutions Inc. filed an 8-K on March 14, 2025, reporting on shareholder nominations pursuant to Exchange Act Rule 14a-11 and other events. The filing date for the report is March 13, 2025. The company's principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.

Why It Matters

This filing indicates potential changes or discussions regarding the company's board composition, which could impact strategic direction and governance.

Risk Assessment

Risk Level: low — The filing is procedural and does not disclose immediate financial risks or significant operational changes.

Key Players & Entities

FAQ

What specific shareholder nominations were made?

The filing does not specify the details of the shareholder nominations, only that they are being reported pursuant to Exchange Act Rule 14a-11.

What are the 'Other Events' mentioned in the filing?

The filing lists 'Other Events' as an item information category but does not provide specific details within the provided text.

When was the earliest event reported in this 8-K?

The earliest event reported in this 8-K was on March 13, 2025.

What is the company's principal executive office address?

The company's principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.

What is the SEC file number for Intelligent Bio Solutions Inc.?

The SEC file number for Intelligent Bio Solutions Inc. is 001-39825.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 14, 2025 regarding INTELLIGENT BIO SOLUTIONS INC. (INBS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing